ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.27
0.17%
US Tech 100
20,576.00
-1.05%
S&P 500
5,955.25
-0.47%
US Dollar vs CAD
1.43055
0.20%
Bitcoin
88,250.00
-3.51%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. TransMedics Group Inc (TMDX) Share Price

TransMedics Group Inc

TransMedics Group Inc (TMDX)

NASDAQ
72.99
-4.13
(-5.36%)
At close: February 25 3:00PM
Delayed by 15 minutes
73.00
0.01
( 0.01% )
After Hours: 3:11PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
73.00
Bid
72.50
Ask
73.80
Volume
2,125,255
72.37 Day's Range 76.33
55.00 52 Week Range 177.37
Market Cap
2.45B
Previous Close
77.12
Open
75.505
Last Trade
1
@
74.99
Last Trade Time
15:12:16
Financial Volume
US$ 156,937,536
VWAP
73.8441
Average Volume (3m)
1,976,510
Shares Outstanding
33,561,517
Dividend Yield
-
PE Ratio
-99.10
Earnings Per Share (EPS)
-0.75
Revenue
241.62M
Net Profit
-25.03M

About TransMedics Group Inc

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a porta... TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body. Show more

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Website
www.transmedics.com
Headquarters
Andover, Massachusetts, USA
Founded
-
TransMedics Group Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker TMDX. The last closing price for TransMedics was US$77.12. Over the last year, TransMedics shares have traded in a share price range of US$ 55.00 to US$ 177.37.

TransMedics currently has 33,561,517 shares outstanding. The market capitalization of TransMedics is US$2.59 billion. TransMedics has a price to earnings ratio (PE ratio) of -99.10.

Ask ADVFN Intelligence (AI)

TransMedics (TMDX) Options Flow Summary

TMDX Options Flow

Overall Flow

Bullish

Net Premium

520k

Calls / Puts

180.00%

Buys / Sells

16.67%

OTM / ITM

133.33%

Sweeps Ratio

0.00%

TMDX Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
February 21 2025
TMDX (-5.36%)

Form 8-K - Current report
Edgar (US Regulatory)
January 14 2025
TMDX (-5.36%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 11 2024
TMDX (-5.36%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.49-0.66675738195773.4979.99571.5012135635476.18229384CS
411.5318.75711729361.4779.99560.46134024471.5383417CS
12-4.465-5.763893371277.46582.3755197651067.46522502CS
26-103.01-58.5250838021176.0117755172691391.04552301CS
52-9-10.975609756182177.37551282718100.81243757CS
15656.73348.67854947816.27177.3716.0476385283.15856501CS
26055.57318.81812966217.43177.371057237171.48500514CS

TMDX - Frequently Asked Questions (FAQ)

What is the current TransMedics share price?
The current share price of TransMedics is US$ 73.00
How many TransMedics shares are in issue?
TransMedics has 33,561,517 shares in issue
What is the market cap of TransMedics?
The market capitalisation of TransMedics is USD 2.59B
What is the 1 year trading range for TransMedics share price?
TransMedics has traded in the range of US$ 55.00 to US$ 177.37 during the past year
What is the PE ratio of TransMedics?
The price to earnings ratio of TransMedics is -99.1
What is the cash to sales ratio of TransMedics?
The cash to sales ratio of TransMedics is 10.26
What is the reporting currency for TransMedics?
TransMedics reports financial results in USD
What is the latest annual turnover for TransMedics?
The latest annual turnover of TransMedics is USD 241.62M
What is the latest annual profit for TransMedics?
The latest annual profit of TransMedics is USD -25.03M
What is the registered address of TransMedics?
The registered address for TransMedics is 200 MINUTEMAN ROAD, ANDOVER, MASSACHUSETTS, 01810
What is the TransMedics website address?
The website address for TransMedics is www.transmedics.com
Which industry sector does TransMedics operate in?
TransMedics operates in the ELECTROMEDICAL APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ICCTiCoreConnect Inc
US$ 1.90
(58.35%)
412.31k
SEZLSezzle Inc
US$ 351.00
(19.71%)
10.49k
HCTIHealthcare Triangle Inc
US$ 0.449555
(15.57%)
179.9k
VEROVenus Concept Inc
US$ 0.6019
(11.42%)
2.77M
AXONAxon Enterprise Inc
US$ 544.08
(9.47%)
20.54k
XHGXChange TED Inc
US$ 0.9759
(-11.28%)
12.6k
GOGrocery Outlet Holding Corporation
US$ 14.35
(-8.89%)
58.19k
RETOReTo Eco Solutions Inc
US$ 1.00
(-6.10%)
200.38k
FMSTForemost Clean Energy Ltd
US$ 0.81
(-5.81%)
270
STTKShattuck Labs Inc
US$ 1.81
(-5.73%)
6.48k
VEROVenus Concept Inc
US$ 0.6019
(11.42%)
2.77M
SOFISoFi Technologies Inc
US$ 13.9105
(-0.07%)
1.68M
SMCISuper Micro Computer Inc
US$ 46.11
(1.27%)
1.41M
NVDANVIDIA Corporation
US$ 126.8003
(0.25%)
1.3M
AMZNAmazon.com Inc
US$ 213.22
(0.21%)
961.02k

TMDX Discussion

View Posts
Monksdream Monksdream 10 months ago
TMDX new 52+ week high
👍️0
Monksdream Monksdream 1 year ago
TMDX 10Q
👍️0
make it happen make it happen 1 year ago
Should touch $50 net lose widens, and has a 40% day. The structure shows over 100% ownership which technically should be illegal. How can there be over 100%? Imho mean institutions and whomever will be selling for a 40%ish profit overnight.
👍️0
crudeoil24 crudeoil24 4 years ago
TransMedics Late Tuesday Announced FDA Advisory Committee Panel Voted 12 To 5 That Benefits Of OCS Heart System Outweigh Risks
6:58 am ET April 7, 2021 (Benzinga) Print
TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics' clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol ("CAP") results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration ("FDA") has issued a favorable vote in support of approval of the OCS Heart System to the FDA's Office of Health Technology 2 (Cardiovascular Devices). The panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh its risks. The panel voted 10 to 6, with 2 abstaining, that there is reasonable assurance that the OCS Heart System is effective. The panel voted 9 to 7, with 2 abstaining, that there is reasonable assurance of the OCS Heart System's safety.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
👍️0
crudeoil24 crudeoil24 4 years ago
Transmedics group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Lung INSPIRE Trial, OCS Lung Expand Trial, OCs Heart EXPAND and PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. It is also focused on developing additional OCS products for kidney transplantation.
👍️0

Your Recent History

NASDAQ
TMDX
TransMedics
BOV
BMYB34R
Bristol-Myers Squibb
BOV
MDNE3
MOURA DUBEAUX ON
BOV
CSAB4F
SEG AL BAHIA PN
BOV
ISAE-DEB71L1
Isa Energia Brasil
BOV
FDXB34R
Fedex
BOV
BIUS39
BlackRock Institutional ...
NASDAQ
FAAR
First Trust Alternative ...
BOV
CRIP34R
Trip.com
BOV
N1DA34R
NASDAQ
BIT
UB60TC
Unicredit Bank
BIT
P1FSH7
BNP Paribas Issuance
BOV
ZAMP9
Zamp ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads